Xybion to Present at the 2nd China Annual Meeting of Drug Toxicology and Showcase
PR Log - Oct 19, 2012 - MORRIS PLANES, NJ -- Xybion Corporation, a leading solutions provider of software, services and consulting for companies operating in highly regulated environments, announced today it will present and participate in the China Annual Meeting of Drug Toxicology and Showcase in Chengdu, China, on October 24-26, 2012. Xybion and its Pristima Preclinical software suite will be showcased and Xybion’s Carlos Frade, director of preclinical solutions, will present on a panel of experts.
Xybion is a leading provider of software and services for the life sciences industry. The Pristima Suite is an integrated set of software and solutions specifically built to support preclinical drug discovery and end-to-end preclinical process management. Pristima is used as a core preclinical platform by leading CRO’s and drug discovery and development companies worldwide. Said Carlos Frade, Director of Preclinical Solutions for Xybion: “We are excited for the opportunity to present at this prestigious conference in China. As a company, we have been focused on the APAC market for several years and have a local presence in APAC via our Xybion-India offices and center of excellence. We are supporting clients throughout APAC and this conference will afford Xybion an opportunity to present our expertise and thought leadership in Preclinical Toxicology to the growing China market”.
The 2nd China Annual Meeting of Drug Toxicology in Chengdu, China, on October 24-26, 2012 is the most specialized platform for academic exchange in the field of drug toxicology research in China. The attendees are mainly from academia, authority and pharmaceutical industry at home and abroad. The organizing committee invites experts in drug toxicology research field to submit proposals for abstracts, panel discussions, seminars, special topic lectures, and workshops for the 2012 annual meeting and provide each attendee with a variety of opportunities to exchange opinions and share the experiences in toxicology. Xybion will actively participate as a panelist in this year’s meeting.
The Pristima Suite™ is a total preclinical software solution for tracking and managing veterinary facilities and research subjects throughout the preclinical research process. From breeding and ordering through the study submission process, the Pristima Suite™ delivers essential capabilities across the entire drug discovery process to facilitate your entire research program. For over 25 years, global pharma companies and CROs have relied on our flagship Pristima preclinical data management suite for effective, end-to-end processes. Pristima delivers quality, efficiency, and compliance assurance. Today 70 Percent of the top global pharmaceutical companies worldwide leverage Pristima.
About Xybion Corporation:
Xybion Corporation is a global leader in the development and delivery of critical enterprise solutions to highly regulated industries, helping companies lower cost, mitigate risk and accelerate growth, while managing quality and compliance. Xybion supports its global, multi-industry client base with a comprehensive portfolio of interconnected solutions that include: Quality/ governance/risk/compliance, Enterprise Asset Management, Enterprise Content & Information Management & Preclinical Data Management . To support global clients, our Professional Services include; validation, testing, migration, integration, custom application development, business intelligence, project management, training and global support. Our business partners include: EMC, OpenText, IBM and Microsoft. Our Value Proposition is to lower our client’s Total Cost of Ownership (TCO) for essential business processes, mitigate risks, accelerate growth and maintain regulatory compliance.